30 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35215274 | Behavioral, Anti-Inflammatory, and Neuroprotective Effects of a Novel FPR2 Agonist in Two Mouse Models of Autism. | 2022 Jan 28 | 2 |
2 | 33804219 | Regulation of Inflammation and Oxidative Stress by Formyl Peptide Receptors in Cardiovascular Disease Progression. | 2021 Mar 15 | 1 |
3 | 33922064 | The Inflammatory Role of Pro-Resolving Mediators in Endometriosis: An Integrative Review. | 2021 Apr 22 | 1 |
4 | 30773096 | Lipoxin A4 Suppresses IL-1β-Induced Cyclooxygenase-2 Expression Through Inhibition of p38 MAPK Activation in Endometriosis. | 2019 Dec | 2 |
5 | 31059786 | Lipoxin A4 restores oxidative stress-induced vascular endothelial cell injury and thrombosis-related factor expression by its receptor-mediated activation of Nrf2-HO-1 axis. | 2019 Aug | 1 |
6 | 28691579 | Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis. | 2018 Apr | 3 |
7 | 29892010 | Lipoxin A4 Attenuates the Inflammatory Response in Stem Cells of the Apical Papilla via ALX/FPR2. | 2018 Jun 11 | 1 |
8 | 27154726 | Formyl-Peptide Receptor 2/3/Lipoxin A4 Receptor Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease. | 2016 May 31 | 1 |
9 | 27424221 | Epigenetic regulation of the formyl peptide receptor 2 gene. | 2016 Oct | 2 |
10 | 25107986 | Physiological levels of lipoxin A4 inhibit ENaC and restore airway surface liquid height in cystic fibrosis bronchial epithelium. | 2014 Aug 1 | 1 |
11 | 23447017 | Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. | 2013 Feb 27 | 1 |
12 | 23607720 | Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. | 2013 Aug | 3 |
13 | 23643932 | Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄. | 2013 Jun 15 | 1 |
14 | 24358628 | Pro-resolution mediator lipoxin A4 and its receptor in upper airway inflammation. | 2013 Nov | 1 |
15 | 22205391 | Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium. | 2012 Apr 1 | 1 |
16 | 22215599 | Serum amyloid A opposes lipoxin A₄ to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. | 2012 Jan 17 | 1 |
17 | 21555360 | A role for lipoxin A₄ as an anti-inflammatory mediator in the human endometrium. | 2011 Aug | 1 |
18 | 18849442 | LXA4 stimulates ZO-1 expression and transepithelial electrical resistance in human airway epithelial (16HBE14o-) cells. | 2009 Jan | 1 |
19 | 19498085 | International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. | 2009 Jun | 1 |
20 | 19751275 | Lipoxin A(4) metabolites/analogues from two commercial sources have no effects on TNF-alpha-mediated priming or activation through the neutrophil formyl peptide receptors. | 2009 Oct | 6 |
21 | 12393391 | Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. | 2003 Feb 15 | 2 |
22 | 12456400 | Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. | 2003 Apr | 1 |
23 | 12560218 | Leukocyte antiadhesive actions of annexin 1: ALXR- and FPR-related anti-inflammatory mechanisms. | 2003 May 15 | 3 |
24 | 12920210 | Differential signaling of formyl peptide receptor-like 1 by Trp-Lys-Tyr-Met-Val-Met-CONH2 or lipoxin A4 in human neutrophils. | 2003 Sep | 3 |
25 | 12410796 | Phagocyte activation by Trp-Lys-Tyr-Met-Val-Met, acting through FPRL1/LXA4R, is not affected by lipoxin A4. | 2002 Nov | 2 |
26 | 12806051 | Lipid-derived mediators in endogenous anti-inflammation and resolution: lipoxins and aspirin-triggered 15-epi-lipoxins. | 2002 Jan 22 | 1 |
27 | 10688842 | The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor. | 2000 Mar 1 | 2 |
28 | 10872839 | Activation of the chemotactic peptide receptor FPRL1 in monocytes phosphorylates the chemokine receptor CCR5 and attenuates cell responses to selected chemokines. | 2000 May 27 | 1 |
29 | 9892621 | A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. | 1999 Jan 18 | 1 |
30 | 10229829 | T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. | 1999 May 15 | 1 |